PDS Biotechnology Corporation
PDSB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $60 | $57 | $0 | $0 |
| Gross Profit | -$60 | -$57 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $22,566 | $27,762 | $29,431 | $11,255 |
| G&A Expenses | $0 | $15,018 | $12,241 | $10,185 |
| SG&A Expenses | $13,696 | $15,282 | $12,241 | $10,185 |
| Sales & Mktg Exp. | $0 | $264 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $0 | $0 |
| Operating Expenses | $36,261 | $43,045 | $41,672 | $21,439 |
| Operating Income | -$36,321 | -$43,045 | -$41,672 | -$21,439 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2,158 | -$1,303 | -$381 | $4 |
| Pre-Tax Income | -$38,480 | -$44,348 | -$42,054 | -$21,435 |
| Tax Expense | -$869 | -$1,406 | -$1,199 | -$4,516 |
| Net Income | -$37,610 | -$42,942 | -$40,855 | -$16,918 |
| % Margin | – | – | – | – |
| EPS | -1.03 | -1.39 | -1.43 | -0.66 |
| % Growth | 25.9% | 2.8% | -116.7% | – |
| EPS Diluted | -1.03 | -1.39 | -1.43 | -0.66 |
| Weighted Avg Shares Out | 36,453 | 30,952 | 28,599 | 25,597 |
| Weighted Avg Shares Out Dil | 36,453 | 30,952 | 28,599 | 25,597 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,515 | $2,903 | $935 | $4 |
| Interest Expense | $4,673 | $4,206 | $1,317 | $0 |
| Depreciation & Amortization | $60 | $57 | $0 | $5 |
| EBITDA | -$33,747 | -$40,085 | -$40,737 | -$21,430 |
| % Margin | – | – | – | – |